Literature DB >> 10899806

Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome.

E Tierney1, N A Nwokoro, R I Kelley.   

Abstract

Smith-Lemli-Opitz syndrome (SLOS, RSH/SLO syndrome, MIM 270400) is an autosomal recessive multiple malformation/mental retardation syndrome initially described by Smith et al. [1964] that is due to a defect in cholesterol biosynthesis. The behavioral phenotype of Smith-Lemli-Opitz syndrome demonstrates cognitive abilities from borderline intellectual functioning to profound mental retardation, sensory hyperreactivity, irritability, language impairment, sleep cycle disturbance, self-injurious behavior, and autism spectrum behaviors. In a recent study of 28 subjects, 14 subjects (50%) with SLOS also exhibited the behavior of throwing themselves backward in a characteristic upper body movement ("opisthokinesis") and 2 adolescents had a stretching motion of the upper body accompanied by hand flicking [Tierney et al., 1999]. In that same study, 6 of 13 subjects (46%) met the Autism Diagnostic Interview-Revised (ADI-R) algorithm criteria (Lord et al. [1993] Infant Mental Health 14:234-252; Lord et al. [1994] J Autism Dev Disord 24:659-685) and the Diagnostic and Statistical Manual (APA [1994] DSM-IV) diagnostic criteria for autistic disorder. Smith-Lemli-Opitz syndrome is a metabolic disorder that is associated with autism. MRDD Research Reviews 2000;6:131-134. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899806     DOI: 10.1002/1098-2779(2000)6:2<131::AID-MRDD7>3.0.CO;2-R

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  19 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  NRIF is a regulator of neuronal cholesterol biosynthesis genes.

Authors:  Zeljka Korade; Rajappa S Kenchappa; Karoly Mirnics; Bruce D Carter
Journal:  J Mol Neurosci       Date:  2008-08-02       Impact factor: 3.444

3.  A Pilot Study of the Association of Markers of Cholesterol Synthesis with Disturbed Sleep in Smith-Lemli-Opitz Syndrome.

Authors:  Kurt A Freeman; Erin Olufs; Megan Tudor; Jean-Baptiste Roullet; Robert D Steiner
Journal:  J Dev Behav Pediatr       Date:  2016-06       Impact factor: 2.225

4.  DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.

Authors:  Libin Xu; Karoly Mirnics; Aaron B Bowman; Wei Liu; Jennifer Da; Ned A Porter; Zeljka Korade
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

5.  Molecular consequences of altered neuronal cholesterol biosynthesis.

Authors:  Zeljka Korade; Anne K Kenworthy; Károly Mirnics
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

6.  Cognitive functioning and psychiatric disorders in children with a metabolic disease.

Authors:  Annik Simons; François Eyskens; Ann De Groof; Ellen Van Diest; Dirk Deboutte; Robert Vermeiren
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-03-10       Impact factor: 4.785

7.  Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity.

Authors:  S A Masino; M Kawamura; C D Wasser; C A Wasser; L T Pomeroy; D N Ruskin
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

8.  Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.

Authors:  William J Griffiths; Jonas Abdel-Khalik; Peter J Crick; Michael Ogundare; Cedric H Shackleton; Karin Tuschl; Mei Kwun Kwok; Brian W Bigger; Andrew A Morris; Akira Honda; Libin Xu; Ned A Porter; Ingemar Björkhem; Peter T Clayton; Yuqin Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-11       Impact factor: 4.292

Review 9.  Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.

Authors:  Melissa D Svoboda; Jill M Christie; Yasemen Eroglu; Kurt A Freeman; Robert D Steiner
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-05       Impact factor: 3.908

10.  Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome.

Authors:  Zeljka Korade; Libin Xu; Fiona E Harrison; Refayat Ahsen; Sarah E Hart; Oakleigh M Folkes; Károly Mirnics; Ned A Porter
Journal:  Biol Psychiatry       Date:  2013-07-26       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.